Methyl 2-bromoimidazo[1,2-a]pyridine-6-carboxylate, 95.0%, 100mg

3-Bromoquinoline, 98.0%, 25g

5-[(4-tert-butylphenoxy)methyl]-4-ethyl-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

Copper ICP standard solution, ROTI®Star, 250 ml, HDPE

4-Hydroxy-benzaldehyde, min. 98%, for synthesis, 5 g, glass packaging

1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride, 95.0%, 5g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(phenylmethyl)-L-histidine, 97%, 1g

3-METHYLPIPERIDINE-4-CARBOXYLIC ACID HCL, 95.0%, 250mg

4-Amino-1-napthalenesulphonic acid sodium salt tetrahydrate, 95%, 1kg

4-tert-Butylbenzhydrol, 97.0%, 1g

4-(trans-4-Ethylcyclohexyl)benzoic Acid>98.0%(GC)(T)5g

5-(1-benzofuran-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 1g

(S)-(+)-1-Phenylethane-1,2-diol, 95.0%, 100g